FDA Considering Pricey Implant As Treatment For Opioid Addiction
Amid a raging opioid epidemic, many doctors and families in the U.S. have been pleading for better treatment alternatives.
drug costs
Aid-In-Dying: Not So Easy
Starting June 9, terminally ill Californians with six months or less to live can request a doctor’s prescription for medications intended to end their lives peacefully.
If that sounds simple, it won’t be.
By Not Discussing Cost Issues, Doctors, Patients May Miss Chances To Lower Out-Of-Pocket Expenses
Talking about money is never easy.
Pharmaceutical Company Has Hiked Price On Aid-In-Dying Drug
When California’s aid-in-dying law takes effect this June, terminally ill patients who decide to end their lives could be faced with a hefty bill for the lethal medication. It retails for more than $3,000.
Valeant Pharmaceuticals, the company that makes the drug most commonly prescribed by physicians to aid patients who want to end their lives, doubled the drug’s price last year, one month after California lawmakers proposed legalizing the practice.
Coinsurance Trend Means Seniors Likely To Face Higher Out-Of-Pocket Drug Costs, Report Says
Medicare beneficiaries may get dinged with higher prescription drug bills this year because more than half of covered drugs in standalone plans require them to pay a percentage of the cost rather than a flat fee, a new analysis found.
How Medicare Drug Plans Hope To Follow Private Sector Lead
Aetna and Cigna inked deals in early February with drugmaker Novartis that offer the insurers rebates tied to how well a pricey new heart failure drug works to cut hospitalizations and deaths. If the $4,500-a-year drug meets targets, the rebate goes down. Doesn’t work so well?
Medicare To Test New Payment Approaches For Some Prescription Medications
Medicare plans to test new ways to pay for prescription medications given in doctors’ offices and hospital outpatient centers — moves likely to win praise from some policy experts, b
Rising Drug Costs, $500 Million Gap Concerns Lynne Saxton
Eight months into her job as director of the Oregon Health Authority, Lynne Saxton applauded the audience at State of Reform’s annual Portland conference for standing up for coordinated care organizations and getting 95 percent of Oregonians insured.
“My goal is to get everyone eligible on Medicaid and help those moving off Medicaid to insurance,” Lynne Saxton told health policy leaders gathered at the State of Reform on Tuesday.
Poll: Americans Favor Government Action On Drug Prices
Most Americans value the prescription products the drug industry produces, but they sure don’t like the prices and want the federal government to take action, according to a new survey.
Cost Of Diabetes Drugs Often Overlooked
When it comes to treating chronic conditions, diabetes drugs aren’t nearly as sexy as say, Sovaldi, last year’s breakthrough hepatitis C drug that offers a cure for the chronic liver infection at a price approaching six figures.
Pages
- « first
- ‹ previous
- 1
- 2
- 3
